Popular blood thinner associated with higher risk of bleeding complications

Researchers examined three commonly prescribed to patients with blood clots or atrial fibrillation

5:00 AM

Author | Noah Fromson

prescription pad blue yellow sketch
Justine Ross, Jacob Dwyer, Michigan Medicine

When diagnosed with a blood clot or atrial fibrillation, patients are often prescribed anticoagulants, or blood thinners, to prevent a future clot. 

In a study of the three most commonly prescribed blood thinners, the oral anticoagulant rivaroxaban, known by the brand name Xarelto, was associated with a significantly higher risk of bleeding complications than apixaban (brand name Eliquis) and warfarin for patients with blood clots or atrial fibrillation.

The findings, reported at the 2023 American Society of Hematology’s Annual Meeting & Exposition, covered over 10 years of patient data from the Michigan Anticoagulation Quality Improvement Initiative registry. 

The multi-center initiative is sponsored by Blue Cross Blue Shield of Michigan. 

SEE ALSO: Clinical smart watch finds success at identifying atrial fibrillation

“We found the highest rates of bleeding among patients who took rivaroxaban, followed by warfarin and then apixaban,” said Jordan K. Schaefer, M.D., first author and clinical associate professor of hematology at University of Michigan Medical School.

“We followed patients for over two years on average and were able to compare apixaban to rivaroxaban, something that has not yet been done in a randomized clinical trial. While the findings should be confirmed with randomized studies, they may have implications for providers as they select anticoagulants for their patients.”

Through their analysis, researchers found that if 100 patients were followed over one year, rivaroxaban resulted in nearly 40 bleeding events compared to around 25 for warfarin. 

Bleeding events were similar between apixaban and warfarin, but the latter medication was associated with more major bleeds. 

SEE ALSO: Stopping aspirin when on a blood thinner lowers risk of bleeding, study finds

The rate of blood clots was higher with apixaban compared to warfarin, but researchers say it seemed largely driven by other thrombotic events, which included events like heart attacks. 

Of the three medications, apixaban was associated with a lower mortality rate than rivaroxaban and warfarin.

“These three medications are the most commonly prescribed anticoagulants for thrombosis and atrial fibrillation, and it is important that we continue to investigate the possible effect they carry as we attempt to best serve our patients,” said Geoffrey Barnes, M.D., M.Sc., senior author and associate professor of cardiology-internal medicine at U-M Medical School.

Josh Errickson, Ph.D., Xiaowen Kong, Naina Chipalkatti, M.D., Brian Haymart, R.N., Suman L. Wood, M.D., MSCE, and James Froehlich, M.D., M.P.H., all of University of Michigan, Mona A. Ali, PharmD., Corewell Health William Beaumont University Hospital, Scott Kaatz, D.O., M.Sc., Gregory D. Krol, M.D., both of Henry Ford Health. 

Schaefer reports a consulting relationship with Pfizer. Barnes reports a consulting relationship with Pfizer, Bristol-Myers Squibb, Janssen, Bayer, AstraZeneca, Sanofi, Anthos, Abbott Vascular and Boston Scientific.

The opinions, beliefs and viewpoints expressed by the authors do not necessarily reflect those of Blue Cross Blue Shield of any of its employees.

Sign up for Health Lab newsletters today. Get medical tips from top experts and learn about new scientific discoveries every week by subscribing to Health Lab’s two newsletters, Health & Wellness and Research & Innovation.

Sign up for the Health Lab Podcast: Add us on SpotifyApple Podcasts or wherever you get you listen to your favorite shows.


More Articles About: Blood Disorders (Hematology) Coagulation Disorders Cardiovascular: Diseases & Conditions Atrial fibrillation (Afib) Deep Vein Thrombosis (DVT) Cardiovascular: Preventive Cardiology
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories surgeon dark room over surgery patient on hospital table
Health Lab
Women more likely than men to die after heart surgery complications
Despite having no greater chance of developing problems after high risk cardiovascular surgery, women are more likely than men to die from post-operative complications, a University of Michigan-led study suggests.
young adult man standin infront of welcome to michigan yellow sign and a photo next to that one of him sitting with a man standing next to him in glasses and UM badge and button down light blue shirt
Health Lab
Timely CPR saves runner who collapsed during first week of college
Bystander CPR saves a first year college student who collapsed from sudden cardiac arrest while running during his first week of school.
three students standing on stairs in Michigan shirts
Health Lab
From babies needing heart surgeries to Michigan Wolverines
After long congenital heart journeys at University of Michigan Health C.S. Mott Children’s Hospital and U-M Health West, three 2024 Grand Rapids area high school graduates are back at University of Michigan: this time, as official Michigan Wolverines.
Survival flight pilots and person standing by helicopter smiling
Health Lab
Motivational speaker reunites with Survival Flight nurses after sudden aortic dissection
A father and motivational speaker, who experienced an urgent heart problem, reunites with his Survival Flight nurses who helped save his life
yellow measurement yellow twirled around blue colored money signs and RX bottles and pills and shots
Health Lab
The heart of the question: Who can get Medicare-covered weight loss medicine?
Wegovy (semaglutide) now has Medicare approval for coverage among people with obesity and cardiovascular disease but no diabetes; a study looks at what level of risk might make someone eligible.
heart drawing
Health Lab
How common is pacemaker use after heart valve surgery?
People having heart surgery to repair leaking mitral or tricuspid valves may receive a pacemaker more often than necessary — leading to a greater risk for life threatening complications.